Insights

Growing International Market Avicanna's expanding presence into international markets with a focus on North America and South America presents sales opportunities for distributors, healthcare providers, and pharmacy networks seeking to incorporate evidence-based cannabinoid products into their offerings.

Diverse Product Portfolio With a broad range of medical cannabis products including proprietary formulations and indication-specific pharmaceutical candidates, there is potential to upsell to existing clients and attract new partners in medical, wellness, and pharmaceutical sectors seeking innovative cannabinoid solutions.

Educational & Provider Partnerships Avicanna’s collaborations with healthcare organizations and educational initiatives indicate opportunities for sales of professional training, educational materials, and support programs targeted at clinicians, nurse practitioners, and medical institutions expanding into cannabinoid therapies.

Pipeline & Innovation The company's ongoing development of patent-pending drug candidates across dermatology, pain management, and neurological disorders offers prospects for licensing agreements, joint ventures, and strategic partnerships with pharma and biotech companies seeking innovative medical treatments.

Market Leadership & Events Participation in major scientific symposiums and industry events, such as the upcoming clinical symposium on cannabinoid therapeutics, creates opportunities to showcase products, establish thought leadership, and engage with key decision-makers to accelerate sales and partnerships in the cannabinoid healthcare space.

Similar companies to Avicanna Inc. (TSX:AVCN)/ MyMedi

Avicanna Inc. (TSX:AVCN)/ MyMedi Tech Stack

Avicanna Inc. (TSX:AVCN)/ MyMedi uses 8 technology products and services including LinkedIn Ads, Google Analytics 4, Salesforce Marketing Cloud, and more. Explore Avicanna Inc. (TSX:AVCN)/ MyMedi's tech stack below.

  • LinkedIn Ads
    Advertising
  • Google Analytics 4
    Analytics
  • Salesforce Marketing Cloud
    Marketing Performance Measurement
  • Yoast SEO
    Search Engines
  • Google
    Search Engines
  • Vimeo
    Video Players
  • GoDaddy
    Web Hosting
  • bxSlider
    Web Tools And Plugins

Media & News

Avicanna Inc. (TSX:AVCN)/ MyMedi's Email Address Formats

Avicanna Inc. (TSX:AVCN)/ MyMedi uses at least 1 format(s):
Avicanna Inc. (TSX:AVCN)/ MyMedi Email FormatsExamplePercentage
First.Last@avicanna.comJohn.Doe@avicanna.com
87%
First.Middle@avicanna.comJohn.Michael@avicanna.com
10%
FirstMiddle.Last@avicanna.comJohnMichael.Doe@avicanna.com
2%
FL@avicanna.comJD@avicanna.com
1%

Frequently Asked Questions

Where is Avicanna Inc. (TSX:AVCN)/ MyMedi's headquarters located?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN)/ MyMedi's main headquarters is located at 661 University Avenue 1300 Toronto, Ontario m5g 0b7 Canada. The company has employees across 4 continents, including North AmericaSouth AmericaEurope.

What is Avicanna Inc. (TSX:AVCN)/ MyMedi's official website and social media links?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN)/ MyMedi's official website is avicanna.com and has social profiles on LinkedInCrunchbase.

What is Avicanna Inc. (TSX:AVCN)/ MyMedi's SIC code NAICS code?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN)/ MyMedi's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Avicanna Inc. (TSX:AVCN)/ MyMedi have currently?

Minus sign iconPlus sign icon
As of April 2026, Avicanna Inc. (TSX:AVCN)/ MyMedi has approximately 74 employees across 4 continents, including North AmericaSouth AmericaEurope. Key team members include Chief Executive Officer: A. A.Vice President - Operations: T. W.Vice President Commercial Operations Europe / Latam: J. K.. Explore Avicanna Inc. (TSX:AVCN)/ MyMedi's employee directory with LeadIQ.

What industry does Avicanna Inc. (TSX:AVCN)/ MyMedi belong to?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN)/ MyMedi operates in the Biotechnology Research industry.

What technology does Avicanna Inc. (TSX:AVCN)/ MyMedi use?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN)/ MyMedi's tech stack includes LinkedIn AdsGoogle Analytics 4Salesforce Marketing CloudYoast SEOGoogleVimeoGoDaddybxSlider.

What is Avicanna Inc. (TSX:AVCN)/ MyMedi's email format?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN)/ MyMedi's email format typically follows the pattern of First.Last@avicanna.com. Find more Avicanna Inc. (TSX:AVCN)/ MyMedi email formats with LeadIQ.

How much funding has Avicanna Inc. (TSX:AVCN)/ MyMedi raised to date?

Minus sign iconPlus sign icon
As of April 2026, Avicanna Inc. (TSX:AVCN)/ MyMedi has raised $2.1M in funding. The last funding round occurred on Aug 01, 2021 for $2.1M.

When was Avicanna Inc. (TSX:AVCN)/ MyMedi founded?

Minus sign iconPlus sign icon
Avicanna Inc. (TSX:AVCN)/ MyMedi was founded in 2016.

Avicanna Inc. (TSX:AVCN)/ MyMedi

Biotechnology ResearchOntario, Canada51-200 Employees

Avicanna is a life sciences company focused on advancement and commercialization of evidence-based cannabinoid products for the global medical and pharmaceutical market segments. Avicanna has an established scientific platform including R&D & clinical development that has led to the commercialization of 30+ products across various market segments: 

•	Medical Cannabis & Wellness Products (RHO Phyto™): The formulary offers a diverse range of proprietary formulations including oral, sublingual, topical, & transdermal deliveries with varying ratios of cannabinoids and is supported with ongoing patient, and medical community education. RHO Phyto is a leading medical brand in Canada and is currently available nationwide to patients across several medical channels and continues to expand into new international markets.

•	Pharmaceutical Preparations and Pipeline: Leveraging Avicanna’s scientific platform, vertical integration, and real-world evidence, Avicanna has an extensive pipeline of indication-specific, patent-pending drug candidates in various stages of clinical development and commercialization. These drug candidates aim to address unmet medical needs in dermatology, chronic pain, and various neurological disorders. Avicanna’s first pharmaceutical preparation (Trunerox™) is approved in Colombia and is in registration in other South American markets.

•	MyMedi.ca Medical Cannabis Care: MyMedi.ca is a medical cannabis care platform formed with the aim to better serve medical cannabis patients’ needs and enhance the patient journey. MyMedi.ca is operated by Northern Green Canada Inc., and features a diverse portfolio of products and pharmacist-led patient support programs. It also provides specialty services to distinct patient groups such as veterans and collaborates with public and private providers for adjudication and reimbursement. MyMedi.ca provides educational resources to facilitate the incorporation of medical cannabis into health care regimens.

Section iconCompany Overview

Headquarters
661 University Avenue 1300 Toronto, Ontario m5g 0b7 Canada
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $2.1M

    Avicanna Inc. (TSX:AVCN)/ MyMedi has raised a total of $2.1M of funding over 1 rounds. Their latest funding round was raised on Aug 01, 2021 in the amount of $2.1Mas a secured term loan financing.

  • $1M$10M

    Avicanna Inc. (TSX:AVCN)/ MyMedi's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $2.1M

    Avicanna Inc. (TSX:AVCN)/ MyMedi has raised a total of $2.1M of funding over 1 rounds. Their latest funding round was raised on Aug 01, 2021 in the amount of $2.1Mas a secured term loan financing.

  • $1M$10M

    Avicanna Inc. (TSX:AVCN)/ MyMedi's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.